Momentum Mover BioCryst (BCRX) Down On Stock Offering
Momentum mover BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is down 8% in pre-open action after announcing plans to offer 5,000,000 shares of its common stock.
Shares of BioCryst are up 800% YTD due to swine flu fears. Recently BioCryst received orders from the U.S. for 10,000 courses of intravenous peramivir for H1N1 after the company was granted emergency use authorization from the FDA after a request by the CDC.
Shares of BioCryst are up 800% YTD due to swine flu fears. Recently BioCryst received orders from the U.S. for 10,000 courses of intravenous peramivir for H1N1 after the company was granted emergency use authorization from the FDA after a request by the CDC.
You May Also Be Interested In
- Savient Pharma (SVNT) Moves Higher with Volatility; Bumps Up Against Key Resistance Point
- Chesapeake (CHK) Shares Jump Into Positive Territory, Now Up 0.5%
- When Will Rosetta Genomics (ROSG) Crash From its 1346% Gain?
Create E-mail Alert Related Categories
Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
